Evidence map›Paper›PMID 36369169›Full record

ArticleNature communications2022

Dominant ARF3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish.

Giulia Fasano, Valentina Muto, Francesca Clementina Radio, Martina Venditti, Niloufar Mosaddeghzadeh, Simona Coppola, Graziamaria Paradisi, Erika Zara, Farhad Bazgir, Alban Ziegler and 28 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Arfs on the Golgi: four conductors, one orchestra.Frontiers in molecular biosciences · 2025
    Review
  7. Article
  8. Article
  9. Characterization of the smallbioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 12 institutions in 4 countries.

Giulia Fasano *Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID 0000-0003-4807-153X
Valentina Muto *Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Francesca Clementina Radio *Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID 0000-0003-1993-8018
Martina VendittiGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Niloufar MosaddeghzadehInstitute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Simona CoppolaNational Center for Rare Diseases, Istituto Superiore di Sanità, 00161, Rome, Italy.
Graziamaria ParadisiGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Erika ZaraGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Farhad BazgirInstitute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-0689-7926
Alban ZieglerUFR Santé de l'Université d'Angers, INSERM U1083, CNRS UMR6015, MITOVASC, SFR ICAT, F-49000, Angers, France.
Giovanni ChillemiDepartment for Innovation in Biological Agro-food and Forest systems (DIBAF), University of Tuscia, 01100, Viterbo, Italy.ORCID 0000-0003-3901-6926
Lucia BertucciniServizio grandi strumentazioni e core facilities, Istituto Superiore di Sanità, 00161, Rome, Italy.ORCID 0000-0002-4278-2376
Antonella TinariCentro di riferimento per la medicina di genere, Istituto Superiore di Sanità, 00161, Rome, Italy.ORCID 0000-0002-7697-814X
Annalisa VetroPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, University of Florence, 50139, Florence, Italy.
Francesca PantaleoniGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID 0000-0003-0765-9281
Simone PizziGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Libenzio Adrian ContiConfocal Microscopy Core Facility, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID 0000-0001-9466-5473
Stefania PetriniConfocal Microscopy Core Facility, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID 0000-0002-3249-0003
Alessandro BrusellesDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161, Rome, Italy.ORCID 0000-0002-1556-4998
Ingrid Guarnetti PrandiDepartment for Innovation in Biological Agro-food and Forest systems (DIBAF), University of Tuscia, 01100, Viterbo, Italy.
Cecilia ManciniGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Balasubramanian ChandramouliSuper Computing Applications and Innovation, CINECA, 40033, Casalecchio di Reno, Italy.
Magalie BarthDépartement de Génétique, CHU d'Angers, 49000, Angers, France.
Céline BrisUFR Santé de l'Université d'Angers, INSERM U1083, CNRS UMR6015, MITOVASC, SFR ICAT, F-49000, Angers, France.
Donatella MilaniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122, Milan, Italy.
Angelo SelicorniMariani Center for Fragile Children Pediatric Unit, Azienda Socio Sanitaria Territoriale Lariana, 22100, Como, Italy.
Marina MacchiaioloGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Michaela V GonfiantiniGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Andrea BartuliGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Riccardo MarianiDepartment of Laboratories Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Cynthia J CurryGenetic Medicine, Dept of Pediatrics, University of California San Francisco, Ca, Fresno, Ca, San Francisco, CA, 94143, USA.
Renzo GuerriniPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, University of Florence, 50139, Florence, Italy.
Anne SlavotinekGenetic Medicine, Dept of Pediatrics, University of California San Francisco, Ca, Fresno, Ca, San Francisco, CA, 94143, USA.
Maria IasconeMedical Genetics, ASST Papa Giovanni XXIII, 24127, Bergamo, Italy.
Bruno DallapiccolaGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Mohammad Reza AhmadianInstitute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-2034-8894
Antonella LauriGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy. antonella.lauri@opbg.net.ORCID 0000-0003-2260-182X
Marco TartagliaGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy. marco.tartaglia@opbg.net.ORCID 0000-0001-7736-9672
Bambino Gesù Children's Hospital · ITIstituto Superiore di Sanità · ITDüsseldorf University Hospital · DEUniversità degli Studi della Tuscia · ITCentre National de la Recherche Scientifique · FRMeyer Children's Hospital · ITUniversity of California, San Francisco · USAzienda Socio Sanitaria Territoriale Lariana · ITCentre Hospitalier Universitaire d'Angers · FRCineca · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITOspedale Papa Giovanni XXIII · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vesicle biogenesis, trafficking and signaling via Endoplasmic reticulum-Golgi network support essential developmental processes and their disruption lead to neurodevelopmental disorders and neurodegeneration. We report that de novo missense variants in ARF3, encoding a small GTPase regulating Golgi dynamics, cause a developmental disease in humans impairing nervous system and skeletal formation. Microcephaly-associated ARF3 variants affect residues within the guanine nucleotide binding pocket and variably perturb protein stability and GTP/GDP binding. Functional analysis demonstrates variably disruptive consequences of ARF3 variants on Golgi morphology, vesicles assembly and trafficking. Disease modeling in zebrafish validates further the dominant behavior of the mutants and their differential impact on brain and body plan formation, recapitulating the variable disease expression. In-depth in vivo analyses traces back impaired neural precursors' proliferation and planar cell polarity-dependent cell movements as the earliest detectable effects. Our findings document a key role of ARF3 in Golgi function and demonstrate its pleiotropic impact on development.

Indexed as

Neurodevelopmental DisordersZebrafishADP-Ribosylation FactorsAnimalsEndoplasmic ReticulumGolgi ApparatusHumansADP-Ribosylation FactorsARF3 protein, human

Identifiers

PMID36369169
PMCPMC9652361
OpenAlexW4309046894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.